rs12720744

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000789.4(ACE):​c.3691+5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00628 in 1,606,582 control chromosomes in the GnomAD database, including 101 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 30 hom., cov: 33)
Exomes 𝑓: 0.0054 ( 71 hom. )

Consequence

ACE
NM_000789.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00003931
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.942

Publications

3 publications found
Variant links:
Genes affected
ACE (HGNC:2707): (angiotensin I converting enzyme) This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020]
ACE Gene-Disease associations (from GenCC):
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • intracerebral hemorrhage
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 17-63496990-C-T is Benign according to our data. Variant chr17-63496990-C-T is described in ClinVar as [Benign]. Clinvar id is 256805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0143 (2181/152092) while in subpopulation AFR AF = 0.036 (1489/41370). AF 95% confidence interval is 0.0345. There are 30 homozygotes in GnomAd4. There are 1065 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 30 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACENM_000789.4 linkc.3691+5C>T splice_region_variant, intron_variant Intron 24 of 24 ENST00000290866.10 NP_000780.1 P12821-1B4DKH4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACEENST00000290866.10 linkc.3691+5C>T splice_region_variant, intron_variant Intron 24 of 24 1 NM_000789.4 ENSP00000290866.4 P12821-1
ENSG00000264813ENST00000577647.2 linkn.1969+5C>T splice_region_variant, intron_variant Intron 13 of 30 2 ENSP00000464149.1 F6X3S4

Frequencies

GnomAD3 genomes
AF:
0.0143
AC:
2179
AN:
151974
Hom.:
30
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0360
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0160
Gnomad ASJ
AF:
0.0184
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00113
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.00435
Gnomad OTH
AF:
0.0225
GnomAD2 exomes
AF:
0.00746
AC:
1752
AN:
234768
AF XY:
0.00699
show subpopulations
Gnomad AFR exome
AF:
0.0335
Gnomad AMR exome
AF:
0.0111
Gnomad ASJ exome
AF:
0.0190
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00100
Gnomad NFE exome
AF:
0.00497
Gnomad OTH exome
AF:
0.0167
GnomAD4 exome
AF:
0.00544
AC:
7915
AN:
1454490
Hom.:
71
Cov.:
34
AF XY:
0.00550
AC XY:
3978
AN XY:
723130
show subpopulations
African (AFR)
AF:
0.0376
AC:
1251
AN:
33268
American (AMR)
AF:
0.0111
AC:
490
AN:
44138
Ashkenazi Jewish (ASJ)
AF:
0.0205
AC:
532
AN:
25974
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39394
South Asian (SAS)
AF:
0.00272
AC:
232
AN:
85348
European-Finnish (FIN)
AF:
0.000820
AC:
43
AN:
52420
Middle Eastern (MID)
AF:
0.0383
AC:
167
AN:
4358
European-Non Finnish (NFE)
AF:
0.00404
AC:
4482
AN:
1109592
Other (OTH)
AF:
0.0120
AC:
718
AN:
59998
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
406
811
1217
1622
2028
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0143
AC:
2181
AN:
152092
Hom.:
30
Cov.:
33
AF XY:
0.0143
AC XY:
1065
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.0360
AC:
1489
AN:
41370
American (AMR)
AF:
0.0160
AC:
245
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0184
AC:
64
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4824
European-Finnish (FIN)
AF:
0.00113
AC:
12
AN:
10622
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.00434
AC:
295
AN:
68008
Other (OTH)
AF:
0.0222
AC:
47
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.534
Heterozygous variant carriers
0
113
226
338
451
564
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00943
Hom.:
8
Bravo
AF:
0.0165
Asia WGS
AF:
0.00606
AC:
21
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Renal tubular dysgenesis Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
1.1
DANN
Benign
0.56
PhyloP100
-0.94
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000039
dbscSNV1_RF
Benign
0.018
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12720744; hg19: chr17-61574351; API